Related Experiment Video
Updated: Jun 5, 2025

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
Atopic dermatitis
Stuart Carr1, Rebecca Pratt2, Fred White3
1Snö Asthma & Allergy, Abu Dhabi, United Arab Emirates. stuart.carr@snoclinics.com.
Atopic dermatitis (AD) is a chronic skin condition impacting quality of life. Newer treatments like JAK inhibitors and biologics offer improved safety and efficacy for managing AD symptoms and improving patient outcomes.
Area of Science:
- Dermatology
- Immunology
- Genetics
Background:
- Atopic dermatitis (AD) is a prevalent chronic skin disorder significantly affecting patient quality of life (QoL).
- Its pathogenesis involves a complex interaction of skin barrier defects, environmental factors, and immune system dysregulation.
- Diagnosis relies on clinical criteria as specific diagnostic tests are unavailable.
Purpose of the Study:
- To provide a comprehensive overview of atopic dermatitis (AD) management.
- To discuss current and emerging therapeutic strategies for AD.
- To highlight the impact of AD on patient QoL and the benefits of new treatments.
Main Methods:
- Review of current literature on AD pathogenesis, diagnosis, and treatment.
- Analysis of the efficacy and safety profiles of various therapeutic agents.
- Discussion of the role of newer systemic agents (JAK inhibitors, biologics) versus traditional therapies.
Main Results:
- Successful AD management requires a multifaceted approach including education, skin care, and pharmacologic treatments.
- Topical corticosteroids are first-line treatments and may aid in prophylaxis.
- Newer systemic agents, including Janus Kinase (JAK) inhibitors and biologics, demonstrate improved safety and efficacy over older immunosuppressives.
Conclusions:
- While prognosis is generally favorable, severe AD with comorbidities can lead to poorer outcomes.
- Newly approved systemic agents significantly enhance QoL for patients with moderate to severe AD.
- Continued research into AD pathogenesis and treatment is crucial for improving patient care.
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Accessory Structures of the Skin: Sebaceous Glands
These glands that produce the oils on the skin and hair are holocrine glands. The mature...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Allergic Reactions
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

